Insufficient scRNA-seq data for expression of AHRR at single-cell level.
Insufficient scRNA-seq data for expression of AHRR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
spleen | 100% | 1569.02 | 241 / 241 | 0% | 0 | 0 / 0 |
skin | 100% | 1516.11 | 1805 / 1809 | 0% | 0.00 | 1 / 472 |
ovary | 89% | 709.60 | 160 / 180 | 0% | 0 | 0 / 430 |
intestine | 80% | 469.36 | 772 / 966 | 0% | 0.01 | 2 / 527 |
thymus | 76% | 384.62 | 496 / 653 | 0% | 0 | 0 / 605 |
lung | 73% | 589.63 | 422 / 578 | 1% | 0.01 | 8 / 1155 |
uterus | 68% | 417.38 | 115 / 170 | 0% | 0 | 0 / 459 |
bladder | 67% | 930.19 | 14 / 21 | 0% | 0.01 | 1 / 504 |
esophagus | 65% | 310.26 | 946 / 1445 | 0% | 0 | 0 / 183 |
prostate | 61% | 239.50 | 150 / 245 | 0% | 0 | 0 / 502 |
breast | 56% | 191.93 | 259 / 459 | 0% | 0.00 | 1 / 1118 |
stomach | 55% | 202.59 | 198 / 359 | 0% | 0.01 | 1 / 286 |
adipose | 54% | 235.63 | 647 / 1204 | 0% | 0 | 0 / 0 |
kidney | 51% | 162.25 | 45 / 89 | 0% | 0.00 | 1 / 901 |
brain | 50% | 185.85 | 1327 / 2642 | 0% | 0 | 0 / 705 |
adrenal gland | 37% | 137.11 | 95 / 258 | 0% | 0.01 | 1 / 230 |
blood vessel | 29% | 83.29 | 381 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 24% | 1494.07 | 221 / 929 | 0% | 0 | 0 / 0 |
pancreas | 22% | 42.14 | 72 / 328 | 0% | 0 | 0 / 178 |
heart | 17% | 51.14 | 149 / 861 | 0% | 0 | 0 / 0 |
liver | 8% | 28.40 | 19 / 226 | 0% | 0 | 0 / 406 |
muscle | 7% | 65.21 | 54 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030522 | Biological process | intracellular receptor signaling pathway |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0034751 | Cellular component | aryl hydrocarbon receptor complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0004879 | Molecular function | nuclear receptor activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0000976 | Molecular function | transcription cis-regulatory region binding |
Gene name | AHRR |
Protein name | Aryl hydrocarbon receptor repressor (HCG1985585, isoform CRA_a) Aryl hydrocarbon receptor repressor Aryl hydrocarbon receptor repressor (AhR repressor) (AhRR) (Class E basic helix-loop-helix protein 77) (bHLHe77) |
Synonyms | BHLHE77 hCG_1985585 KIAA1234 |
Description | FUNCTION: Mediates dioxin toxicity and is involved in regulation of cell growth and differentiation. Represses the transcription activity of AHR by competing with this transcription factor for heterodimer formation with the ARNT and subsequently binding to the xenobiotic response element (XRE) sequence present in the promoter regulatory region of variety of genes. Represses CYP1A1 by binding the XRE sequence and recruiting ANKRA2, HDAC4 and/or HDAC5. Autoregulates its expression by associating with its own XRE site. . |
Accessions | E5RHE0 ENST00000652417.2 A0A494BZY4 ENST00000515206.6 A9YTQ3 ENST00000511487.1 H0YA43 ENST00000506456.1 ENST00000504625.1 ENST00000514523.1 ENST00000684583.1 E5RGQ2 ENST00000316418.10 D6RE68 G3V143 E5RFG4 A0A7I2PK40 ENST00000510400.5 |